Wednesday, October 17, 2018

CERS Boosts Revenue Outlook, KOOL Hands Out Pink Slips, EIGR'S UTLRA Study Fails

Today's Daily Dose brings you news about Celcuity's clinical trial agreement with Puma; Cerus' upbeat revenue outlook; workforce reduction at Cesca; positive results from pilot study of Cannabics capsules; and Eiger's disappointing results from ULTRA study.

from RTT - Biotech https://ift.tt/2QTGW5m
via IFTTT

No comments:

Post a Comment